CAS 1092539-44-0

Formel: C18H22N4O4

InChl: InChI=1S/C18H22N4O4/c1-5-22-15(19)13(17(24)20-3)14(23)12-7-6-11(21-16(12)22)8-9-18(2,25)10-26-4/h6-7,25H,5,10,19H2,1-4H3,(H,20,24)

InChI Key: PFMPOBVAYMTUOX-UHFFFAOYSA-N

SMILES: CCN1C(=C(C(=O)C2=C1N=C(C=C2)C#CC(C)(COC)O)C(=O)NC)N

(-)-2-Amino-1-Ethyl-7-(3-Hydroxy-4-Methoxy-3-Methylbut-1-Yn-1-Yl)-N-Methyl-4-Oxo-1,4-Dihydro-1,8-Naphthyridine-3-Carboxamide

CAS: 1092539-44-0

(-)-2-Amino-1-Ethyl-7-(3-Hydroxy-4-Methoxy-3-Methylbut-1-Yn-1-Yl)-N-Methyl-4-Oxo-1,4-Dihydro-1,8-Naphthyridine-3-Carboxamide

Formel: C₁₈H₂₂N₄O₄

Reinheit: ≥98%

Molekulargewicht: 358.39

Ref: 54-OR1024022

(Rac)-SAR131675

CAS: 1092539-44-0

(Rac)-SAR131675

Formel: C₁₈H₂₂N₄O₄

Reinheit: ≥98%

Molekulargewicht: 358.39

Ref: 54-BUP07430

2-Amino-1-ethyl-7-(3-hydroxy-4-methoxy-3-methyl-1-butyn-1-yl)-n-methyl-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxamide

CAS: 1092539-44-0

Formel: C₁₈H₂₂N₄O₄

Reinheit: 98%

Molekulargewicht: 358.3917

Ref: IN-DA008Z8E

SAR-131675

CAS: 1092539-44-0

Ref: 7W-GW6041

(Rac)-SAR131675

CAS: 1092539-44-0

(Rac)-SAR131675 is an effective and specific VEGFR-3 inhibitor, which inhibited VEGFR-3 tyrosine kinase activity and VEGFR-3 autophosphorylation in HEK cells.

Formel: C₁₈H₂₂N₄O₄

Reinheit: 98.73% - 99.1%

Farbe und Form: Solid

Molekulargewicht: 358.3917

Ref: TM-T3691

2-Amino-1-ethyl-7-(3-hydroxy-4-methoxy-3-methylbut-1-yn-1-yl)-N-methyl-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxamide

CAS: 1092539-44-0

Formel: C₁₈H₂₂N₄O₄

Reinheit: 95%

Molekulargewicht: 358.398

Ref: 10-F521421

SAR131675

CAS: 1092539-44-0

SAR131675 is a drug that acts as a tyrosine kinase inhibitor. It has been shown to have an effect on the growth of cancer cells and has been shown to be effective in treating inflammatory bowel disease. SAR131675 inhibits the activity of protein tyrosine kinases, which are enzymes that phosphorylate proteins and regulate their biological functions. The drug is selective for certain kinases, such as c-kit, stem cell factor receptor (c-Kit), and platelet-derived growth factor receptor (PDGFR). SAR131675 has been shown to be safe and effective in treating diseases such as cancer or inflammatory bowel disease when administered at an effective dose.

Formel: C₁₈H₂₂N₄O₄

Reinheit: Min. 95%

Molekulargewicht: 358.39 g/mol

Ref: 3D-STB53944